Application of traditional Chinese medicine composition in preparation of medicine for preventing and treating coronary heart disease PCI postoperative restenosis

Abstract

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to application of a ginseng foundation-consolidating traditional Chinese medicine composition prepared from ginseng, rehmannia, poria cocos, moutan bark, prepared rehmannia root, dogwood, Chinese yam, rhizoma alismatis, asparagus cochinchinensis and radix ophiopogonis in preparation of medicines for preventing and / or treating coronary heart disease PCI postoperative restenosis.

Description

technical field [0001] The invention relates to a new application of a traditional Chinese medicine composition, in particular to the application of the traditional Chinese medicine composition in preparing a medicine for treating restenosis after PCI, and belongs to the technical field of medicine. Background technique [0002] Coronary heart disease (CHD) is one of the diseases that seriously endanger human health. Statistics show that the incidence and mortality of CHD in my country are on the rise. Percutaneous coronary intervention (PCI) has become an important method for the treatment of coronary heart disease, but the rate of restenosis (RS) in stent 6 months after operation is as high as 30-50%, seriously affecting its long-range efficacy. The application of various stents has greatly reduced the restenosis rate after PCI, but it still cannot be cured, which limits the clinical application and development of PCI. Therefore, the prevention and treatment of restenosis...

AI Technical Summary

Problems solved by technology

However, long-term use of antiplatelet drugs such as clopidogrel and aspirin increases the risk of bleeding and may also induce other diseases

Images